Label: SALICYLIC ACID solution

  • NDC Code(s): 54295-304-11
  • Packager: Trinity Pharmaceuticals, LLC
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated March 22, 2023

If you are a consumer or patient please visit this version.

  • PATIENT PACKAGE INSERT

    Rx only

    FOR DERMATOLOGICAL USE ONLY. NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.

    DESCRIPTION

    Salicylic Acid, 27.5% is a topical preparation containing 27.5% Salicylic Acid in a film-forming vehicle composed of: acrylates copolymer, isopropyl alcohol, isobutyrate, n-butyl acetate, and polyvinyl butyrate. The pharmacologic activity of this medication is generally attributed to the keratolytic activity of salicylic acid which is incorporated into a film-forming vehicle designed to cover the wart without the need for a bandage. The chemical structural formula of salicylic acid is:

    chemical structure

    CLINICAL PHARMACOLOGY

    Although the exact mode of action for salicylic acid in the treatment of warts is unknown, its activity appears to be associated with its keratolytic action, which results in mechanical removal of epidermal cells infected with wart viruses.

    INDICATIONS AND USES

    Salicylic Acid, 27.5% is indicated for the topical treatment and removal of common warts and plantar warts.

    CONTRAINDICATIONS

    Salicylic Acid, 27.5% should not be used by diabetics or patients with impaired blood circulation. Salicylic Acid, 27.5% should not be used on moles, birthmarks, unusual warts with hair growing from them or warts on the face.

    PRECAUTIONS

    Salicylic Acid, 27.5% is for external use only. Do not permit Salicylic Acid, 27.5% to contact eyes or mucous membranes. If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. Salicylic Acid, 27.5% should not be allowed to contact normal skin surrounding the wart. Treatment should be discontinued if excessive irritation occurs. Salicylic Acid, 27.5% is flammable and should be kept away from fire or flame.  Keep bottle tightly capped when not in use.

    ADVERSE REACTIONS

    A localized irritant reaction may occur if Salicylic Acid, 27.5% is applied to the normal skin surrounding the wart. Any irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed.

    DOSAGE AND ADMINISTRATION

    Prior to application of Salicylic Acid, 27.5% soak wart in warm water for five minutes. Remove any loosened tissue by gently rubbing with a brush, wash cloth, emery board or pumice stone. Dry thoroughly. Using the brush applicator supplied, apply twice to entire wart surface, allowing the first application to dry before applying the second. Treatment should be once or twice a day and should continue as directed by physician. Be careful not to apply to surrounding skin.  Clinically visible improvement will normally occur during the first or second week of therapy. Maximum resolution may be expected after four to six weeks of drug use.

    HOW SUPPLIED

    Salicylic Acid, 27.5% is supplied in 10 mL amber glass bottles with brush applicator - NDC 54295-304-11.

    Store at 20ºC to 25ºC (68ºF to 77ºF)., excursions permitted between 15ºC and 30ºC (between 59ºF and 86ºF). Brief exposure to temperatures up to 40ºC (104ºF) may be tolerated provided the mean kinetic temperature does not exceed 25ºC (77ºF); however, such exposure should be minimized. Protect from freezing.

  • SPL UNCLASSIFIED SECTION

    KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN.

    Marketed By:
    Trinity Pharmaceuticals LLC
    1 International Plaza, Suite 550
    Philadelphia, PA 19113
    TrinityPharmaLLC.com
    REV 11/13

  • Salicylic Acid, 27.5% 10 mL Container Label Principal Display Panel Text:

    NDC 54295-304-11

    Rx only

    For topical use only
    Not for ophthalmic use

    Salicylic Acid, 27.5%
    10 mL

    Salicylic Acid, 27.5% carton Label
  • INGREDIENTS AND APPEARANCE
    SALICYLIC ACID 
    salicylic acid solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:54295-304
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID275 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    BUTYL ACETATE (UNII: 464P5N1905)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54295-304-111 in 1 CARTON11/16/2013
    110 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other11/16/2013
    Labeler - Trinity Pharmaceuticals, LLC (078671698)